|
|
Many of these trials have produced groundbreaking data on the treatment of hypertension such as ALLHAT, CONVINCE, and INVEST. Besides contributing to the growing body of knowledge, these trials provide our patients with access to promising medications before they are approved for the marketplace. The care is free and most patients benefit from the close monitoring of our physicians and research staff.
Our research staff is composed of a professional group of study coordinators who are solely dedicated to clinical research. These coordinators have over 30 years of research expertise in cardiovascular disorders such as hypertension, coronary artery disease, diabetes, and dyslipidemia. All patients' rights and care are protected by federal mandates, which are strictly adhered to in research protocols.
The Hypertension Institute strives to offer our patients access to the latest information, medications and technology in the treatment of hypertension. In support of this mission, we have conducted clinical trials on site for major pharmaceutical companies such as Pfizer, Novartis, Merck and others, as well as research in the areas of neutraceuticals and supplements.
